Advertisement
Screener

GeneDx Holdings Corp. (WGS) Unbilled Receivables, Current

2.8 / 5 stars · 68/120 Roast Me

GeneDx Holdings Corp. Unbilled Receivables, Current

GeneDx Holdings Corp. (WGS) had Unbilled Receivables, Current of $2.90 million as of 2023-06-30, per its 10-Q filed 2023-08-08.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:UnbilledReceivablesCurrent · last filed 2023-08-08

  • 2023-06-30: Unbilled Receivables, Current $2.90M.
  • 2023-03-31: Unbilled Receivables, Current $2.90M.
  • 2022-12-31: Unbilled Receivables, Current $1.50M.
  • 2022-09-30: Unbilled Receivables, Current $3.60M.
Period endUnbilled Receivables, Current
2023-06-30$2.90M
10-Q · filed 2023-08-08
2023-03-31$2.90M
10-Q · filed 2023-05-09
2022-12-31$1.50M
10-Q · filed 2023-08-08
2022-09-30$3.60M
10-Q · filed 2022-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B